Porphyria in Hodgkin's disease by Falkson, H.C. et al.
2 January 1971 S.A. MEDICAL JOURNAL 19
fascia' also suggests the diagnosis of rupture of a bron-
chus.
Complications
If the patient survives and treatment is not prompt,
three main complications may be expected.
Atelectasis. The effects of atelectasis after successful
bronchial anastomosis have been studied by Mahaffey
et al.s Findings such as may be encountered in a right-
to-left shunt are reported. They also noted a lower vital
capacity, decreased oxygen uptake and a decreased pul-
monary compliance.
Bronchial stenosis. There is no uniformity of thought
as to the frequency with which stenosis will result from
an untreated fractured bronchus.",,5,7,9-11
Pulmonary sepsis. This is the most severe complication.
Although Drapanas et al.'· report a case of complete
reversal of bronchiectasis after re-anastomosing the two
bronchial ends, it is felt that this is the exception rather
than the rule. Coxatto and Lanari," in their study of the
pathogenesis of bronchiectasis, feel that where there is
complete obstruction to the distal bronchus, bronchial
secretion will cease before irreparable damage has been
done because of a pressure build-up due to bronchial
secretions.
Mahaffey et al.' reported a case of complete recovery
after anastomosis was done, where only a sterile gelati-
nous plug was aspirated from the distal segment. If, how-
ever, secondary infection develops, permanent damage is
almost inevitable. This unhappy finding occurs in about
25% of cases, mostly those where the obstruction is in-
complete.13
Treatment
Although cases of successful repair of ruptured bronchi
have been reported as long as 11 years after the fracture
had occurred," the treatment of choice is immediate re-
anastomosis of the fracture, or suturing of the laceration
with interrupted black silk or wire sutures.
SUMMARY
Two cases of fractured bronchi which have been successfully
treated have been reported. Traumatic fractures of the bronchi
following blunt chest trauma have been discussed in general
and the importance of early repair to prevent stenosis and/or
permanent lung damage has been stressed again.
REFERENCES
1. Burke, J. F. (1962): J. Amer. Med. Assoc., 181, 683.
2. Hood, R. M. and Sloan, H. E. (1959): 1. Thorac. Cardiovasc. Surg.,
38, 458.
3. Krinitsky, S. t. (1927): Virchows Arch. path. Anal., 266, 815.
4. Griffith, J. L. (1949): Thorax, 4, 105.
5. Ballershy, J. S. and Jilman, J. W. (1964): Arch. Surg., 88, 644.
6. Marchand, P. (195t): Thorax, 6, 359.
7. Adarns, W. E. (1966): J. Amer. Med. Assoc., 198, 299.
8. MahafIey. D. E., Oscar, C. jnr, Hollis, G. B. and DeBakey, M. E.
(1956): J. Thorac. Surg., 32, 312.
9. Winter, B. and Baum, R. (1968): J. Amer. Med. Assoc., 206, 370.
10. Drapanas, T., Siewers, R. and Feist, J. H. (1966): New Engl. J. Med.,
275, 917.
11. Ozonoff, M. B. (1964): Cali£. Med.. 100. 14.
12. Coxatta, O. C. and Lanari, A. (1954): J. Thorac. SUTg., 27, 5t4.
13. Reynolds, J. and Christensen, E. E. (1968): Tex. SI. J. Med., 64,50.
PORPHYRIA IN HODGKIN'S DISEASE*
H. C. FALKSON, M.D., Department of Cancer Chemotherapy, E. J. SCHULZ, M.MED. (DERM.), Department of
Dermatology, AND GEOFFREY FALKSON, M.D., Department of Cancer Chemotherapy, H. F. Verwoerd Hospital and
University of Pretoria, Pretoria
Varied and perplexing skin lesions are found in the
course of Hodgkin's disease. A survey of the world
literature shows that 20 - 50% of patients have significant
complaints referable to the skin; no cases with concomi-
tant porphyria have as yet been reported.
Although porphyrin was referred to and described as
far back as the last century'" and the term porphyria was
first used by Waldenstrom' more than 30 years ago, many
aspects of this enigmatic condition still await clarification.
Indeed, even the classification of porphyrias must await
more knowledge regarding their inter-relationships, and
is constantly being revised. The most useful current
cIassificati0n is shown in Table I!
The following case report draws attention to a hitherto
unpublished concomitant metabolic disorder occurring
during the course of Hodgkin's dis::ase.
CASE REPORT
A 39-year-old diamond cutter was referred to our clinic
with the diagnosis of Hodgkin's disease of mixed cell
type (Luke's classification). Biopsies were performed on
an enlarged lymph gland in the left inguinal area and
kin from the pubic area. About 4 months previously he
starte~ complaining of pruritus, weight loss, fever and
sweatmg.
When the patient was first seen in our clinic he was
'Date received: 28 August 1970.
TABLE 1. CLASSIFlCAHON OF PORPHYRtAS (1970)'
1. Erythropoietic porphyria
(a) recessive (classical congenital porphyria)
(b) dominant (porphyria erychropoiecica et hepacica or-
erythropoietic protoporphyria or coproporphyria)
2. Acute intermittent porphyria
(a) manifest
(b) latent
3. Hepatic cutaneous porphyria
(a) hereditary
(i) porphyria cutanea tarda or protocoproporphyria
(ii) mixed porphyria
(iii) variegate porphyria
(b) acquired
(i) symptomatic porphyria cutanea tarda
(ii) Bantu porphyria
(iii) hexachlorobenzene porphyria
(iv) griseofulvin porphyria
(v) porphyria of hepatic adenoma
4. Experimental porphyria
found to be very ill with a deep jaundice, severe nausea..
and pain over the right hypochondrium and lower back.
He further complained of loss of appetite and a moderate
'dead feeling' of all fingers. Examination showed hilateral
multiple enlarged lymph glands of the groins as well as
a large, hard swelling of the anterior pubic area, and
hepatomegaly. A severe ichthyosis of the whole body
was present.
The following laboratory results were obtained at this.
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time: Haemoglobin 13·5 g/ 100 ml, platelets 229000/ mm'.
white cells 25000/mm3 with a differential count of 90%
polymorphonuclear cells, 4% Iymphocytes and 6% mono-
cytes. The Coombs test was negative, and a bone-marrow
'examination showed no abnormalities. Blood urea was 34
mg/ 100 ml, uric acid was 3·8 mg/ 100 ml, creatinine was 1·5
mg/100 ml, serum calcium was 10·6 mg/ 100 ml, and serum
'copper was 190 p.g/ 100 ml. The sedimentation rate was 40
mm (Westergren), bilirubin direct/indirect was 1'5/0'8 mg
/100 ml, SGOT was 23 Cabaud units, alkaline phosphatase
32 KA units, serum albumin 2·6 g/100 ml, serum globu-
lin 4·7 g/100 ml and serum gammaglobulin 1·5 g/100 ml.
A marked bilirubinuria was present.
Intensive combination chemotherapy was started imme-
'<liately. By the 8th day of treatment the liver was no
longer palpable, the adenopathy was very much smaller
and the pubic swelling half the initial size. Both pruritus
and pain had cleared, and the generalized ichthyosis was
only mild. The patient's appetite improved. The icterus
was only mild, sedimentation rate was down to 10 mm,
bilirubin was normal, SGOT was 12 Cabaud units, serum
albumin 3·3 g/ 100 ml, serum globulin 4·2 g/lOO ml, alka-
line phosphatase 22 KA units. Serum copper was still
200 p.g/lOO ml.
By the 28th day the jaundice had cleared, there was
no bilirubinuria, serum albumin was 3·7 g/l00 ml and
serum globulin 3·3 g/l00 m!. Alkaline phosphatase was
still above normal (20 KA units). Serum copper was
162 p.g/lOO m\. Serum electrophoresis remained normal
and the alkaline phosphatase gradually became normal.
An occasional abnormal value was still periodically re-
corded for SGOT and SGPT tests. By day 169 all tests
indicative of liver function were normal, and they have
remained so up till the present time. On day 176 the
patient complained of blisters on both hands. He was
found to have several large (up to 1·5 cm by 0·5 cm)
subepidermal bullae, mainly on the dorsae of both hands
(Figs. I and 2). These bullae contained a colourless fluid,
and in other areas the blisters were broken and crusted
over. No bullae occurred on the rest of the body.
Urine and faeces were positive for porphyrins. Quanti-
tative and qualitative tests were performed. The faeces
showed an increased coproporphyria of 50·86 p.g/ g dry
Fig. 1. The typical appearance of the patient's hands. A
large unruptured bulla can be seen on the ring finger of
the right hand.
Fig. 2. Scarring and depigmentation as well as crusted,
ruptured bullae are clearly visible on the dorsae of both
hands.
faeces, and an increase of protoporphyrins to 71·87 p.g/ g
dry faeces. No uroporphyrins were present. In the urine the
coproporphyrins were greatly increased to 152·66 p.gjIitre
urine, while no uroporphyrins were found.
The patient was in complete remission from the Hodg-
kin's disease 170 days after treatment was started and is
still in complete remission 10 months after the commence-
ment of treatment. The cutaneous porphyria has remained
present, which is rather irksome in his work.
DISCUSSION
In this patient several skin lesions occurred: specifically
Hodgkin's disease of the skin (as was shown by the
biopsy of the pubic area), the non-specific ichthyosis of
Hodgkin's disease (which cleared on successful treatment
of the Hodgkin's disease) and lastly, an unusual concomi-
tant porphyria with typical skin lesions. When the por-
phyria presented shortly after grossly abnormal liver
function was restored, it was thought to be an acquired
symptomatic form of porphyria cutanea tarda based on
malfunction of the liver. An interesting aetiological as-
pect observed by Gajdos-Torok' is the rather frequent
appearance of cutaneous porphyria in patients with rare
diseases of haematological character. This could also fit
in with our patient. The age and sex of this patient,
absence of serious photosensitivity, no family history of
porphyria, the fact that administration of barbiturates
had had no adverse effects on him, and of course the
acquired liver malfunction, suggested a symptomatic por-
phyria cutanea tarda. Differentiation between symptomatic
porphyria and genetic porphyria on purely clinical grounds
may be impossible."'; Quantitative and qualitative bio-
chemical findings in the excreta (increased copro- and
protoporphyrins with absence of uroporphyrins) indicate
that this patient probably has a porphyria cutanea tarda
hereditaria (protocoproporphyria of Waldenstrom) or
else the so-called 'variegate' porphyria of White Soutb
Africans.
The aetiological mechanism for the development of
porphyria awaits clarification. An elevation of the por-
phyrins or their precursors in urine and faeces is the
chemical hallmark of the porphyrias; this may be caused
either by a block in haem biosynthesis or, more likely.
-
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SUM~IARY
Skin lesions are very common in Hodgkin's disease, but no
cases with concomitant porphyria have as yet been reported.
A case is presented where protocoproporphyria with typical
skin involvement occurred when the patient with advanced
Hodgkin's disease. and severe liver involvement was in com-
plete remission. Biochemical difIerentiation between sympto-
matic porphyria cutanea tarda and genetic porphyria showed
that this patient has the latter form. The possi ble inter-
relationship between Hodgkin's disease and the metabolic
defect of porphyrin metabolism is discussed.
We wish to thank Dr J. L. Meiring, pathologist. for the
quantitative and qualitative porphyrin determinations.
maintenance therapy for I week before the appearance
of the bullae.
Chlorambucil (N- '-dil2-chloroethyl)-p-amino-phenyl-bu-
tyric acid) is one of the oldest alkylating agents and has
been in clinical use since 1954. It has been given for
long periods in a vast number of patients throughout the
world, and has never precipitated an attack of porphyria.
This may perhap be because the incidence of porphyria
is only 0'2 uu" or 0 07°u for outh African genetic por-
phyria.
by increased production of porphyrin precursors. Investi-
gations suggest that increased amounts of glycine or delta-
;minolaevulinic acid are available for porphyrin biosyn-
thesis. Since S-aminolaevulinic acid is a common precur-
sor for both porphyrin and purine biosynthesis, it has
been suspected that an abberation in purine metabolism
may represent part of the hepatic porphyrias. Since the
first symptoms of cutaneous porphyria the patient's serum
uric acid has remained elevated, ranging from 7·5 to 8·8
mg/100 m!. The coexistence of porphyria and hyperuri-
caemia may seem paradoxical, if a block in the manufac-
ture of purines is a defect in porphyria. However, meta-
bolic defects like gout and porphyria are not incompatible;
and the presence of hyperuricaemia does not necessarily
negate the possibility that a block exists in the formation
of purines.
The case reported here presents a complex problem
regarding the aetiology of the porphyria: (l) this may be
a patient with porphyria variegata, totally unrelated to
the Hodgkin's disease; (h) the porphyria may be part
of the Hodgkin's disease-although concomitant porphy-
ria and Hodgkin's disease have never before been docu-
mented, id reactions of bullae and vesicles during the
course of Hodgkin's disease have been reported;'1O but
the cases were not investigated for porphyria (hydroa
aestivale is not at all uncommon in Hodgkin's disease,
and it has been noted" that some cases of so-called hydroa
aestivale or polymorphous light eruption may well be"
due to porphyria); (iii) lastly, the question arises whether
a chemotherapeutic agent may have been a precipitating
factor in a patient with a genetic defect. The porphyria
occurred when the patient was already in complete re-
mission with normal liver function; 3 weeks had elapsed
since intensive combination chemotherapy had been
stopped; and he had been receiving chlorambucil as
PASSING EVENTS : IN DIE VERBYGAAN
**
Drr. J. H. T. ReYl/eke en F. J. Z. Booysen, interniste. praktiseer
vanaf 1 Januarie 1971 in vennootskap te Listergebou 907,
Jeppestraat 195, Johannesburg. Telefoonnommers: spreek-
kamers 23-1498, 23-2346.
**
University of the Wirwatersrand Medical Graduates Associa-
liol/ Luncheon Club. The next meeting will be held on Tuesday
12 January at 1.00 p.m. in the Blue Room, Station Concourse,
Johannesburg. Miss M. Bryant, Public Relations Officer, Jo-
hannesburg Stock Ex.change, will speak on 'The function of
the stock exchange'. The cost of the luncheon is R1.55 per
head,. a~d all interested persons are welcome to attend.
Application should be made to the Secretary, Medical Gradu-
ates ASSOCiatIOn, Medical School, Hospital Street, Johannes-
burg (telephone 724-6456).
Universiteil van Slellenbosch, Fakulleil van Geneeskunde, Op- l/llernarional Agency for Research on Cal/cer, Research
kl/appingskursus in Radiologie vir Mediese Praktisyns. 'n .' Training Fellowships 1971 - 1972. Applications for training
Opknappingskursus in radiologie, aangebied deur die Fakulteit 'fellowships in 1971 - 1972 are invited from junior scientists
van Geneeskunde van die Universiteit van Stellenbosch, sal wishing to be trained in any aspect of laboratory and clinical
gehou word op 16 en 17 Januarie'1971 in die Kart Breine~.: .., cancer research. The Agency is especially interested in re-
hospitaal, Bellville, K.P. Die kursus volg op vorige kursusse iiJ ceiving applications for training in epidemiology, biostatistics
radiologie en interne geneeskunde wat sedert 1968 aangebied is. and all aspects of environmental biology. Applicants should
Hierdie opknappingskursus handel oor verskeie aspekte van be engaged in research in medical or allied sciences and intend
radiologiese diagnose en radiologiese behandeling in verband to pursue a career in cancer research. .
met kanker, tuberkulose, artritis, vrouesiektes, amebiase en Fellowships are awarded for I year and are tenable in a
bilharzia. Daar sal ook besoek gebring word aan die radio- suitable institution abroad. Fellows will, in general, be selected
terapeutiese en radiodiagnostiese afdelings van die hospitaal. froin applicants with less than 5 years' postgraduate experience
Die kursus strek oor It dag vanaf Vrydagoggend om 9.00' Xrn. in medicine or the natural sciences. They must have an ade-
tot Saterdag om 12.00 middag, en vind plaas onder die leidmg quate knowledge, both written and spoken, of the language
van prof. C. J. B. Muller, hoogleraar in radiologie. Die lesings of the country in which their fellowship is tenable.
word deur lede van die personeel van hierdie departement ge- Applications cannot normally be accepted from people
lewer. ' already holding fellowships enabling them to study abroad.
Inskrywing kan tot 8 Januarie 1971 gedoen word en navrae Stipends will vary according to the cost of living in the
en inskrywings kan gerig word aan die Sekretaris, Opknappings- country of study. The cost of travel for the applicant and.
kursus in Radiologie, Fakulteit van Geneeskunde, Posbus 53, in certain circumstances, that of his wife and children, will
Bellville, K.P. (telefoon: 97-5761). be met.
Fellowship application forms and more detailed information
are available from the Chief of the Research Training and
Liaison Unit, International Agency for Research on Cancer,
16, Avenue Marechal-Foch, 69 - Lyon (6 E ) France. Applica-
tions must reach the Agency not later than 28 February 1971.
